BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 27530685)

  • 1. The gut microbiota: a key regulator of metabolic diseases.
    Yang JY; Kweon MN
    BMB Rep; 2016 Oct; 49(10):536-541. PubMed ID: 27530685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota, obesity and metabolic disorders.
    Federico A; Dallio M; DI Sarno R; Giorgio V; Miele L
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):337-344. PubMed ID: 28927249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota in health and disease: an overview focused on metabolic inflammation.
    Nagpal R; Kumar M; Yadav AK; Hemalatha R; Yadav H; Marotta F; Yamashiro Y
    Benef Microbes; 2016; 7(2):181-94. PubMed ID: 26645350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connection between gut microbiome and the development of obesity.
    Zhi C; Huang J; Wang J; Cao H; Bai Y; Guo J; Su Z
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):1987-1998. PubMed ID: 31367997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crosstalk between gut microbiota and obesity and related metabolic disorders.
    Xu WT; Nie YZ; Yang Z; Lu NH
    Future Microbiol; 2016 Jun; 11():825-36. PubMed ID: 27192213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial Metabolites Determine Host Health and the Status of Some Diseases.
    Sittipo P; Shim JW; Lee YK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
    Agus A; Clément K; Sokol H
    Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota.
    Wisniewski PJ; Dowden RA; Campbell SC
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30626117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction.
    Mavilio M; Marchetti V; Fabrizi M; Stöhr R; Marino A; Casagrande V; Fiorentino L; Cardellini M; Kappel B; Monteleone I; Garret C; Mauriello A; Monteleone G; Farcomeni A; Burcelin R; Menghini R; Federici M
    Cell Rep; 2016 Jul; 16(3):731-43. PubMed ID: 27373162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-3 polyunsaturated fatty acids: An innovative strategy against obesity and related metabolic disorders, intestinal alteration and gut microbiota dysbiosis.
    Bellenger J; Bellenger S; Escoula Q; Bidu C; Narce M
    Biochimie; 2019 Apr; 159():66-71. PubMed ID: 30690133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota and Metabolic Disorders: Advances in Therapeutic Interventions.
    Akash MSH; Fiayyaz F; Rehman K; Sabir S; Rasool MH
    Crit Rev Immunol; 2019; 39(4):223-237. PubMed ID: 32421966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents.
    Ejtahed HS; Soroush AR; Angoorani P; Larijani B; Hasani-Ranjbar S
    Horm Metab Res; 2016 Jun; 48(6):349-58. PubMed ID: 27203411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet-microbiota interactions as moderators of human metabolism.
    Sonnenburg JL; Bäckhed F
    Nature; 2016 Jul; 535(7610):56-64. PubMed ID: 27383980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes.
    Scheithauer TPM; Rampanelli E; Nieuwdorp M; Vallance BA; Verchere CB; van Raalte DH; Herrema H
    Front Immunol; 2020; 11():571731. PubMed ID: 33178196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of intestinal microbiota and microbial metabolites in metabolic control.
    Herrema H; IJzerman RG; Nieuwdorp M
    Diabetologia; 2017 Apr; 60(4):613-617. PubMed ID: 28013341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intestinal microbiota fuelling metabolic inflammation.
    Tilg H; Zmora N; Adolph TE; Elinav E
    Nat Rev Immunol; 2020 Jan; 20(1):40-54. PubMed ID: 31388093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Gut Microbiota in the development of obesity and Diabetes.
    Baothman OA; Zamzami MA; Taher I; Abubaker J; Abu-Farha M
    Lipids Health Dis; 2016 Jun; 15():108. PubMed ID: 27317359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the gut microbiota on inflammation, obesity, and metabolic disease.
    Boulangé CL; Neves AL; Chilloux J; Nicholson JK; Dumas ME
    Genome Med; 2016 Apr; 8(1):42. PubMed ID: 27098727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Western diets, gut dysbiosis, and metabolic diseases: Are they linked?
    Martinez KB; Leone V; Chang EB
    Gut Microbes; 2017 Mar; 8(2):130-142. PubMed ID: 28059614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.